Checks the signs linked with successful removal of VA-ECMO, measured at minimal ECMO flow during a weaning trial, against Aissaoui 2011 and the ELSO 2021 VA-ECMO guideline.
How to read the result
| Result | Meaning |
|---|
| Met | All signs present at minimal flow. In Aissaoui 2011, every patient who tolerated a full weaning trial and had aortic VTI 10 cm or more, LVEF above 20-25% and lateral S′ 6 cm/s or more was weaned. |
| Borderline | All signs present, but LVEF falls in the 20-25% zone the study gave as its cut-off |
| Not met | One or more signs missing; the list shows which |
| ELSO text is stricter | Shown with Met or Borderline when VTI is 10-12 cm or LVEF is under 30%: the ELSO text uses VTI above 12 cm and LVEF 25-30% or more |
The signs support the team’s decision and do not make it: the study had 51 patients, and its authors called for validation.
Criteria
| Sign at minimal ECMO flow | Threshold used | Source | ELSO 2021 |
|---|
| ECMO flow | 1.5 L/min or less | ELSO 2021 | 1 to 1.5 L/min in the algorithm figure; evaluate at 1 L/min, or after 3-5 minutes clamped |
| Aortic (LVOT) VTI | 10 cm or more | Aissaoui 2011 | Above 12 cm in the text (printed as 0.12 m/s); above 0.15 in the algorithm figure |
| LVEF | Above 20-25% | Aissaoui 2011 | 25-30% or more; above 30% in the figure |
| Lateral mitral annulus S′ (tissue Doppler) | 6 cm/s or more | Aissaoui 2011 | 6 cm/s or more |
| Mean arterial pressure | Above 60 mmHg | ELSO 2021 | Above 60 mmHg; above 65 at 2-2.5 L/min before a trial |
| Pulse pressure | Above 10 mmHg | ELSO 2021 | Above 10 mmHg |
| Vasoactive support | Low doses of one or two drugs | ELSO 2021 | Doses below |
Aissaoui and colleagues reduced flow to under 1.5 L/min; the ELSO algorithm uses 1 to 1.5 L/min, so 1.5 L/min counts as low flow here. Replying to a letter on the weaning criteria, the guideline authors confirmed the VTI discrepancy: the guideline value is above 12 cm, the source they used gives at least 10 cm at an ECMO flow of 1-1.5 L/min, 12 cm is the safest threshold, and 15 cm suggests a fuller recovery. ELSO also published an erratum to the guideline in 2022.
ELSO’s low-dose limits in µg/kg/min: dopamine below 3, dobutamine below 3, milrinone below 0.3, norepinephrine below 0.06, epinephrine below 0.1 and phenylephrine below 1; vasopressin below 0.03 is printed in the same unit, although vasopressin is usually dosed in units/min. ELSO’s text also lists CVP 10 mmHg or less, while its algorithm figure shows CVP below 18 mmHg and cardiac index above 2.2 L/min/m2. During a trial ELSO lowers flow by 500 mL every 5-10 minutes with anticoagulation maintained; a pump-controlled retrograde trial off is an alternative.
Evidence
Aissaoui and colleagues studied 51 adults on VA-ECMO for refractory cardiogenic shock (medical, post-cardiotomy or post-transplant): 38 tolerated at least one flow-reduction trial and 20 were weaned. At each flow level, weaned patients had higher systolic and pulse pressures, aortic VTI, LVEF and lateral S′ than those who tolerated the trial but were not judged weanable, and the echo signs separated the groups better than any other measure. The ELSO 2021 thresholds are consensus.
References
- Aissaoui N, Luyt CE, Leprince P, et al. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med. 2011;37(11):1738-1745. PMID 21965097
- Lorusso R, Shekar K, MacLaren G, et al. ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO J. 2021;67(8):827-844. PMID 34339398
- Lorusso R, Bartlett RH, Shekar K, et al. Reply letter to the editor regarding the ELSO interim guidelines for veno-arterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO J. 2022;68(6):e111-e112. PMID 35649227
- ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients: erratum. ASAIO J. 2022;68(7):e133. PMID 35763786